Corcept Therapeutics (CORT) Exchange Rate Effect (2024 - 2026)
Corcept Therapeutics' (CORT) quarterly Exchange Rate Effect came in at -$287000.0 in Q1 2026, down 180.17% year-on-year from $358000.0 in Q1 2025, and down 796.88% quarter-over-quarter from -$32000.0 in Q4 2025.
Corcept Therapeutics (CORT) Exchange Rate Effect (2024 - 2026) Analysis & Trends
Corcept Therapeutics has disclosed Exchange Rate Effect across 3 years of filings, most recently posting -$287000.0 for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$287000.0, down 180.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $797000.0 (changed N/A YoY), and the FY2025 annual result was $1.4 million, up 732.46% from the prior year.
- Exchange Rate Effect came in at -$287000.0 for Q1 2026 at Corcept Therapeutics, down from -$32000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $1.4 million in Q2 2025 to a low of -$758000.0 in Q4 2024.
- The 3-year median for Exchange Rate Effect is -$32000.0 (2025), against an average of $133285.7.
- Across the five-year window, Exchange Rate Effect jumped 95.78% in 2025 and plunged 180.17% in 2026, its largest moves.
- Corcept Therapeutics' Exchange Rate Effect stood at -$758000.0 in 2024, then surged by 95.78% to -$32000.0 in 2025, then tumbled by 796.88% to -$287000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$287000.0 (Q1 2026), -$32000.0 (Q4 2025), and -$320000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Corcept Therapeutics | 8.35 Bn | 8.01 Bn | 162.02 Mn | -287,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -287,000.00 |
| Mar 31, 2026 | -287,000.00 |
| Dec 31, 2025 | -32,000.00 |
| Dec 31, 2025 | -32,000.00 |
| Sep 30, 2025 | -320,000.00 |
| Sep 30, 2025 | -320,000.00 |
| Jun 30, 2025 | 1.44 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 358,000.00 |
| Mar 31, 2025 | 358,000.00 |
| Dec 31, 2024 | -758,000.00 |
| Dec 31, 2024 | -758,000.00 |
| Sep 30, 2024 | 536,000.00 |
| Sep 30, 2024 | 536,000.00 |